Drawing for ALTUS BIOLOGICS

USPTO serial 76366421

ALTUS BIOLOGICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
EDWARDS, ALICIA COLLINS
Law office
SCANNING ON DEMAND

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALTUS BIOLOGICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer M. Reynolds

JENNIFER M REYNOLDS BROMBERG & SUNSTEIN LLP125 SUMMER STBOSTON, MA 02110-1618UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Proteins and chemicals, namely, antibodies, enzymes, enzyme preparations, glycoproteins, hormones and peptides for general industrial and manufacturing use and for scientific, medical research, and agricultural purposesACTIVE—
005Proteins and chemicals, namely, antibodies, enzymes, enzyme preparations, glycoproteins, hormones and peptides for medical and veterinary clinical and diagnostic use; and proteins and chemicals, namely antibodies, enzymes, enzyme preparations, glycoproteins, hormones and peptides for medical and therapeutic use in the treatment of infectious and parasitic diseases, neoplasms, endocrine diseases, nutritional deficiencies, metabolic diseases and disorders, gastrointestinal diseases and disorders, immunity disorders, diseases of the blood and blood-forming organs, diseases and disorders of the circulatory system, diseases and disorders of the respiratory system, diseases and disorders of the digestive system, diseases and disorders of the genitourinary system, diseases and conditions of the skin and subcutaneous tissue, diseases and disorders of the musculoskeletal system and connective tissue, congenital anomalies, injuries, and poisoning, in humans, livestock, domestic pets, and exotic animalsACTIVE—
010house mark for medical devices, medical apparatus and drug delivery devicesACTIVE—
040Custom manufacture and modification of proteins and chemicals and enzyme preparations for others for general industrial and manufacturing use, medical and veterinary clinical, diagnostic and therapeutic use, and for use in scientific fields, the medical field, and the food, pharmaceutical and agricultural industriesACTIVE—
042Pharmaceutical drug research, design, and development services for others; research, design, development, and testing of proteins, chemicals and enzyme preparations for others; providing technical advice and consultation services in the field of chemistryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 27, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 27, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 17, 2004CFITCASE FILE IN TICRS—
Mar 17, 2004MAILPAPER RECEIVED—
Mar 15, 2004EX1GSOU EXTENSION 1 GRANTED—
Mar 15, 2004EXT1SOU EXTENSION 1 FILED—
Sep 16, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 24, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 4, 2003NPUBNOTICE OF PUBLICATION—
Apr 15, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 17, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 17, 2003MAILPAPER RECEIVED—
Feb 26, 2003MAILPAPER RECEIVED—
Nov 26, 2002CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 28, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 28, 2002MAILPAPER RECEIVED—
May 8, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2002DOCKASSIGNED TO EXAMINER—
Apr 24, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance